Court Denies Validity of AstraZeneca’s Toprol-XL Patent (Seeking Alpha via Yahoo! Finance)
Court Denies Validity of AstraZeneca’s Toprol-XL Patent (Seeking Alpha via Yahoo! Finance)
Aaron F. Barkoff submits: On Monday, the Federal Circuit affirmed a district court summary judgment decision that AstraZeneca’s U.S. Patent No. 5,081,154 is invalid for double patenting.